These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18324369)

  • 1. (18)F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteases.
    Kopka K; Schober O; Wagner S
    Basic Res Cardiol; 2008 Mar; 103(2):131-43. PubMed ID: 18324369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancer.
    Wagner S; Kopka K
    Recent Results Cancer Res; 2013; 187():107-32. PubMed ID: 23179879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligands for imaging myocardial alpha- and beta-adrenoceptors.
    Riemann B; Schäfers M; Law MP; Wichter T; Schober O
    Nuklearmedizin; 2003 Feb; 42(1):4-9. PubMed ID: 12601447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
    Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
    Ghesani M; Depuey EG; Rozanski A
    Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical role of positron emission tomography in management of the cardiac patient.
    Pirich C; Schwaiger M
    Rev Port Cardiol; 2000 Feb; 19 Suppl 1():I89-100. PubMed ID: 10750444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Molecule PET Tracers for Transporter Imaging.
    Kilbourn MR
    Semin Nucl Med; 2017 Sep; 47(5):536-552. PubMed ID: 28826525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative analysis of myocardial glucose metabolism by using dynamic FDG-PET acquisition].
    Sciumbata M; Critello S; Galea D
    Recenti Prog Med; 2012 Nov; 103(11):450-4. PubMed ID: 23096730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients.
    Tagliabue L; Del Sole A
    Eur J Intern Med; 2014 Jan; 25(1):6-11. PubMed ID: 23910561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of positron emission tomography in sarcoidosis].
    Bonardel G; Carmoi T; Gontier E; Lecoules S; Cambon A; Foehrenbach H; Algayres JP
    Rev Med Interne; 2011 Feb; 32(2):101-8. PubMed ID: 20846762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method.
    Herrero P; Dence CS; Sharp TL; Welch MJ; Gropler RJ
    Nucl Med Biol; 2004 Oct; 31(7):883-92. PubMed ID: 15464390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Positron emission tomography (PET): a useful tool for the assessment of cardiac metabolism].
    Alexánderson E; Gómez-Martín D; Benito I; Ruíz-Ramírez L; Ricalde A; Meave A
    Arch Cardiol Mex; 2004; 74(3):220-8. PubMed ID: 15559875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.